Published in J Glaucoma on February 01, 1999
Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci (2009) 1.79
A semiautomated targeted sampling method to assess optic nerve axonal loss in a rat model of glaucoma. Nat Protoc (2010) 1.27
Relationship between orbital optic nerve axon counts and retinal nerve fiber layer thickness measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.16
Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma. Br J Ophthalmol (2005) 1.04
Network analysis of human glaucomatous optic nerve head astrocytes. BMC Med Genomics (2009) 1.03
Expression of ephrinB1 and its receptor in glaucomatous optic neuropathy. Br J Ophthalmol (2007) 0.94
Refined Data Analysis Provides Clinical Evidence for Central Nervous System Control of Chronic Glaucomatous Neurodegeneration. Transl Vis Sci Technol (2014) 0.93
Quantitative 3-T diffusion tensor imaging in detecting optic nerve degeneration in patients with glaucoma: association with retinal nerve fiber layer thickness and clinical severity. Neuroradiology (2013) 0.87
Structure/function studies and the effects of memantine in monkeys with experimental glaucoma. Invest Ophthalmol Vis Sci (2012) 0.79
Refined Frequency Doubling Perimetry Analysis Reaffirms Central Nervous System Control of Chronic Glaucomatous Neurodegeneration. Transl Vis Sci Technol (2015) 0.75
How much is the brain involved in glaucoma? Br J Ophthalmol (2006) 0.75
Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. Ophthalmology (2000) 3.34
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest (1996) 3.10
Discriminating between normal and glaucomatous eyes using the Heidelberg Retina Tomograph, GDx Nerve Fiber Analyzer, and Optical Coherence Tomograph. Arch Ophthalmol (2001) 2.99
Simultaneous indocyanine green and fluorescein angiography using a confocal scanning laser ophthalmoscope. Arch Ophthalmol (1998) 2.96
Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function. Invest Ophthalmol Vis Sci (2001) 2.54
Reproducibility of topographic measurements of the normal and glaucomatous optic nerve head with the laser tomographic scanner. Am J Ophthalmol (1991) 2.48
The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glaucomatous eyes with optical coherence tomography. Arch Ophthalmol (2000) 2.33
Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science (1989) 2.19
Agreement between spectral-domain and time-domain OCT for measuring RNFL thickness. Br J Ophthalmol (2009) 2.12
Acute ascending necrotizing myelopathy caused by herpes simplex virus type 2. Neurology (1987) 2.11
Complications of glaucoma surgery. Ocular decompression retinopathy. Arch Ophthalmol (1992) 2.06
Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Invest Ophthalmol Vis Sci (2000) 1.97
Interpretation of automated perimetry for glaucoma by neural network. Invest Ophthalmol Vis Sci (1994) 1.86
Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol (1994) 1.81
Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci (1999) 1.80
Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma. Invest Ophthalmol Vis Sci (2001) 1.68
Severe vision loss and neovascular glaucoma complicating superior ophthalmic vein approach to carotid-cavernous sinus fistula. Am J Ophthalmol (1997) 1.67
Spatially resolved birefringence of the retinal nerve fiber layer assessed with a retinal laser ellipsometer. Appl Opt (1992) 1.66
Short-wavelength automated perimetry and motion automated perimetry in patients with glaucoma. Arch Ophthalmol (1997) 1.65
Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol (2000) 1.62
Neurofibrillary tangles in progressive supranuclear palsy. Electron microscopic observations. J Neuropathol Exp Neurol (1974) 1.60
Detection of early glaucomatous structural damage with confocal scanning laser tomography. J Glaucoma (1998) 1.56
Nerve regeneration in silicone chambers: influence of gap length and of distal stump components. Exp Neurol (1982) 1.56
The definition of normal-tension glaucoma. J Glaucoma (1998) 1.47
Reproducibility of retardation measurements with the nerve fiber analyzer II. J Glaucoma (1997) 1.45
Liposome suppression of proliferative vitreoretinopathy. Rabbit model using antimetabolite encapsulated liposomes. Invest Ophthalmol Vis Sci (1991) 1.44
Human trabecular cells. I. Establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci (1979) 1.43
A comparison of optical coherence tomography and retinal nerve fiber layer photography for detection of nerve fiber layer damage in glaucoma. Ophthalmology (2000) 1.43
Anterior chamber angle imaging with optical coherence tomography. Eye (Lond) (2011) 1.43
Nocturnal elevation of intraocular pressure in young adults. Invest Ophthalmol Vis Sci (1998) 1.42
Lateral geniculate nucleus in glaucoma. Am J Ophthalmol (1994) 1.40
Agreement between clinicians and a confocal scanning laser ophthalmoscope in estimating cup/disk ratios. Am J Ophthalmol (1995) 1.39
Spatial-temporal progress of peripheral nerve regeneration within a silicone chamber: parameters for a bioassay. J Comp Neurol (1983) 1.39
Assessment of rates of structural change in glaucoma using imaging technologies. Eye (Lond) (2011) 1.39
Reducing corneal toxicity of 5-fluorouracil in the early postoperative period following glaucoma filtering surgery. Aust N Z J Ophthalmol (1991) 1.39
The nonlinear contribution of nitrous oxide at sub-MAC concentrations to enflurane MAC in rats. Anesth Analg (1989) 1.38
Experimental syphilitic orchitis in rabbits: ultrastructural appearance of Treponema pallidum during phagocytosis and dissolution by macrophages in vivo. Lab Invest (1982) 1.37
Using optical imaging summary data to detect glaucoma. Ophthalmology (2001) 1.37
Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography. Am J Ophthalmol (1995) 1.35
The relationship between structural and functional alterations in glaucoma: a review. Semin Ophthalmol (2000) 1.35
Neonatal infection with the Daniels strain of Theiler's murine encephalomyelitis virus. Lab Invest (1983) 1.34
Ethnic differences in optic nerve head topography. J Glaucoma (1995) 1.33
Glycogen accumulation in the nerves and kidney of chronically diabetic rats. A quantitative electron microscopic study. J Neuropathol Exp Neurol (1979) 1.30
Immediate intraocular pressure response to argon laser trabeculoplasty. Am J Ophthalmol (1983) 1.29
Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Arch Ophthalmol (1998) 1.29
Interobserver variability of optic disk variables measured by confocal scanning laser tomography. Am J Ophthalmol (2001) 1.28
Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. Brain Res (1999) 1.28
Optic nerve head topography in ocular hypertensive eyes using confocal scanning laser ophthalmoscopy. Am J Ophthalmol (1996) 1.26
Neurotoxicity of local anesthetics: altered perineurial permeability, edema, and nerve fiber injury. Anesthesiology (1986) 1.26
Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol (1995) 1.24
Effect of inverted body position on intraocular pressure. Am J Ophthalmol (1984) 1.22
A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death Dis (2011) 1.21
Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia (2004) 1.21
Nerve fiber layer measurements with scanning laser polarimetry in ocular hypertension. Arch Ophthalmol (1997) 1.20
Relationship of optic disc topography to optic nerve fiber number in glaucoma. Arch Ophthalmol (1998) 1.19
Pathology of experimental nerve compression. Lab Invest (1986) 1.19
Influence of the number of laser burns administered on the early results of argon laser trabeculoplasty. Am J Ophthalmol (1983) 1.18
Optic neuropathy associated with cryptococcal arachnoiditis in AIDS patients. Am J Ophthalmol (1989) 1.17
Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction. J Exp Med (1995) 1.17
Microangiopathy in human diabetic neuropathy. Acta Neuropathol (1985) 1.17
Effect of cataract and pupil size on image quality with confocal scanning laser ophthalmoscopy. Arch Ophthalmol (1997) 1.15
Change in optic disk topography after trabeculectomy. Am J Ophthalmol (1996) 1.14
Intraocular and episcleral venous pressure increase during inverted posture. Am J Ophthalmol (1987) 1.14
Comparisons of anterior segment biometry between Chinese and Caucasians using anterior segment optical coherence tomography. Br J Ophthalmol (2010) 1.13
Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects. Ophthalmology (1987) 1.13
Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. Arch Ophthalmol (1999) 1.13
Optic disk topography after medical treatment to reduce intraocular pressure. Am J Ophthalmol (2000) 1.11
Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow. Surv Ophthalmol (1997) 1.09
Assessment of the retinal nerve fiber layer in clinical trials of glaucoma neuroprotection. Surv Ophthalmol (2001) 1.09
Early changes in experimental allergic neuritis. Lab Invest (1983) 1.09
Short-wavelength color visual fields in glaucoma suspects at risk. Am J Ophthalmol (1993) 1.08
Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci (1997) 1.08
Microangiopathy of vasa nervorum in dysglobulinemic neuropathy. Ann Neurol (1984) 1.07
Mapping of the major histocompatibility complex and viral antigens on the plasma membrane of a measles virus-infected cell. Virology (1983) 1.07
Uveitis associated with sarcoidosis and angiotensin converting enzyme. Am J Ophthalmol (1980) 1.07
Immune response to hepaitis virus type B in Down's syndrome and other mentally retarded patients. Am J Epidemiol (1972) 1.07
Pressure increase in the dorsal root ganglion following mechanical compression. Closed compartment syndrome in nerve roots. Spine (Phila Pa 1976) (1989) 1.07
Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am J Pathol (1998) 1.07
Active optical depth resolution improvement of the laser tomographic scanner. Appl Opt (1989) 1.06
Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol (1998) 1.06
Imaging of cyclodialysis cleft by ultrasound biomicroscope. Am J Ophthalmol (1994) 1.05
Isolating the effects of primary open-angle glaucoma on the contrast sensitivity function. Am J Ophthalmol (1991) 1.05
Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures. J Neuroimmunol (1988) 1.05
Betaxolol in patients with glaucoma and asthma. Am J Ophthalmol (1986) 1.05
Color perimetry for assessment of primary open-angle glaucoma. Invest Ophthalmol Vis Sci (1990) 1.04
The mechanism of action of prostaglandins on uveoscleral outflow. Curr Opin Ophthalmol (2000) 1.03
The organization of actin filaments in human polymorphonuclear leukocytes. Anat Rec (1984) 1.03
Mapping structural to functional damage in glaucoma with standard automated perimetry and confocal scanning laser ophthalmoscopy. Am J Ophthalmol (1998) 1.02
Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res (1996) 1.02
Evaluating the optic disc and retinal nerve fiber layer in glaucoma. I: Clinical examination and photographic methods. Semin Ophthalmol (2000) 1.02
Increased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F(2 alpha)-isopropyl ester treatment. Arch Ophthalmol (2001) 1.01
Reduced nerve blood flow in edematous neuropathies: a biomechanical mechanism. Microvasc Res (1986) 1.00
Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol Psychiatry (1997) 1.00
Changes in endoneurial fluid pressure, permeability, and peripheral nerve ultrastructure in experimental lead neuropathy. Ann Neurol (1980) 1.00
Acquired dyschromatopsia in glaucoma. Surv Ophthalmol (1986) 0.99